Date:
Source:
HUN-REN Szegedi Biológiai Kutatóközpont
Summary:
Scientists have discovered that DMT, a natural compound found in plants and even the human brain, can dramatically reduce brain damage caused by stroke. The psychoactive molecule, long known for its hallucinogenic effects, restored the blood-brain barrier and reduced inflammation in animal and cell studies. These findings suggest that DMT could complement existing stroke treatments, potentially transforming recovery outcomes.

FULL STORY


DMT Helps the Brain Heal After Stroke
DMT, a natural compound in the brain, has shown powerful protective effects against stroke damage. Scientists believe it could become a groundbreaking addition to modern stroke therapy. Credit: Shutterstock

DMT, or dimethyltryptamine is a natural psychoactive molecule found in many plants and mammals. According to an article published in Science Advances, researchers from the HUN-REN BRC Institute of Biophysics and Semmelweis University Heart and Vascular Centre found that DMT reduces the harmful effects of stroke in animal models and cell culture experiments.

A solution from nature in the spotlight

DMT is also present in the human brain, and it is currently undergoing clinical trials to aid recovery of brain function after stroke. However, its exact mechanism of action had not been fully understood until now. "It is amazing how we can always turn to Nature to find ingenious solutions for health problems" says co-lead author Mária Deli from the HUN-REN BRC.

The blood-brain barrier as a therapeutic target

"We found that DMT significantly reduced infarct volume and edema formation in a rat stroke model," explains co-first author Marcell László. In both animal experiments and cell culture models, the authors showed that DMT treatment restored the structure and function of the damaged blood-brain barrier and improved the function of astroglial cells. This psychoactive compound also inhibited the production of inflammatory cytokines in brain endothelial cells and peripheral immune cells, while reduced the activation of brain microglia cells through Sigma-1 receptors.

DMT could serve as therapeutic adjuvant to existing stroke treatments

"The therapeutic options currently available for stroke are very limited. The dual action of DMT, protecting the blood-brain barrier while reducing brain inflammation, offers a novel, complex approach that could complement existing treatments," says Judit Vigh, co-first author of the work.

Since current stroke therapies do not always result in full recovery, a DMT-based treatment may represent a promising new alternative, mainly in combination with existing methods. The recent findings from researchers in Szeged and Budapest, Hungary, support the development of a therapy that goes beyond the limitations of conventional stroke treatment. Clinical trials on the use of DMT and investigation on its long-term effects are currently ongoing.


Story Source:

Materials provided by HUN-REN Szegedi Biológiai Kutatóközpont. Note: Content may be edited for style and length.


Journal Reference:

  1. Marcell J. László, Judit P. Vigh, Anna E. Kocsis, Gergő Porkoláb, Zsófia Hoyk, Tamás Polgár, Fruzsina R. Walter, Attila Szabó, Srdjan Djurovic, Béla Merkely, Alán Alpár, Ede Frecska, Zoltán Nagy, Mária A. Deli, Sándor Nardai. N , N -dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation. Science Advances, 2025; 11 (33) DOI: 10.1126/sciadv.adx5958[1]

Cite This Page:

HUN-REN Szegedi Biológiai Kutatóközpont. "A psychedelic surprise: DMT helps the brain heal after stroke." ScienceDaily. ScienceDaily, 7 October 2025. <www.sciencedaily.com/releases/2025/10/251006051129.htm>.

HUN-REN Szegedi Biológiai Kutatóközpont. (2025, October 7). A psychedelic surprise: DMT helps the brain heal after stroke. ScienceDaily. Retrieved October 7, 2025 from www.sciencedaily.com/releases/2025/10/251006051129.htm

HUN-REN Szegedi Biológiai Kutatóközpont. "A psychedelic surprise: DMT helps the brain heal after stroke." ScienceDaily. www.sciencedaily.com/releases/2025/10/251006051129.htm (accessed October 7, 2025).

RELATED STORIES


Study Finds Targeting Inflammation May Not Help Reduce Liver Fibrosis in MAFLD[2]

July 26, 2024 — A surprising discovery by UCLA Health researchers may rewrite our understanding of how liver disease progresses. While it's long been believed that inflammation drives the scarring known as ...

Chemists Synthesize Ocean-Based Molecule That Could Fight Parkinson's[3]

Jan. 20, 2023 — Recreating natural molecules in the laboratory as part of the search for potential new drugs for disease can be difficult, costly and slow. The problem? Many chemical processes tend to produce not ...

How an Emerging Drug Class Dampens Harmful Immune Reactions[4]

Nov. 16, 2022 — Although the complement system forms part of the innate immune system, it can cause damage to the body in some cases. This is because unwanted complement activation contributes to many autoimmune and ...

Newly Discovered Barrier Prevents Immunity from Reaching Smell-Sensing Cells[5]

Sep. 21, 2022 — Scientists have identified a previously unknown barrier that separates the bloodstream from smelling cells in the upper airway of mice. But this barrier ends up keeping some of the larger molecules ...

Cannabis Impacts Sperm Counts, Motility in Two Generations of Mice[6]

Dec. 2, 2021 — An intense but short-term exposure to cannabis vapor lowered sperm counts and slowed sperm movement, or motility, not only in the directly exposed male mice but also in their sons, according to a new ...

Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mouse Study[7]

May 25, 2021 — A novel compound similar in structure to the psychedelic drug ibogaine, but lacking its toxic and hallucinogenic effects, has been found to rapidly reverse the effects of stress in mice. Researchers ...

TRENDING AT SCITECHDAILY.com[8]


Scientists Discover a Protein That Literally Punches Holes in the Heart[9]

A Mile-Deep Detector Hints at the Universe’s Darkest Secret[10]

Parkinson’s “Trigger” Seen Directly in the Human Brain for the First Time[11]

Colossal 12,000-Year-Old Rock Art Reveals Forgotten Human Culture in Ancient Arabia[12]

Read more …A psychedelic surprise: DMT helps the brain heal after stroke

Until now, weight reduction has been the primary therapeutic goal for people with prediabetes. An analysis of a large Tübingen study shows that patients who bring their blood sugar levels back within the normal range through a healthy lifestyle but do not lose weight, or even gain weight, still reduce their risk of type 2 diabetes by 71 percent. Researchers from the University Hospital of Tübingen, Helmholtz Munich, and the German Center for Diabetes Research (DZD) were involved in the study.

Millions of people worldwide live with prediabetes. It is estimated that one in ten adults is affected, although the number of unreported cases means the real figure is significantly higher. Prediabetes is a condition in which blood sugar values are elevated but do not yet meet the criteria for diabetes. It often remains undetected for a long time, as affected individuals initially have no symptoms. The body's cells become more resistant to endogenous insulin hormone. As a result, less sugar moves from the blood into the body cells and the blood sugar level increases. The risks are considerable: If left untreated, there is a high risk of developing type 2 diabetes later on -- a disease that affects more than 460 million people worldwide. It can lead to serious complications, such as cardiovascular disease or cancer.

Normal Blood Sugar Level as a Milestone

Strategies recommended to date -- including in current guidelines -- for the prevention of type 2 diabetes in people with prediabetes primarily focus on reducing weight through a healthy diet and increased physical activity. This strategy, which is limited to weight alone, could be broadened on the basis of the new analysis results.

A long-term study conducted by the Department of Diabetology, Endocrinology and Nephrology at the University Hospital Tübingen showed that 234 of the more than 1100 study participants lost no weight or even gained weight over the course of a year despite undergoing lifestyle changes. Nevertheless, a good 22 percent of them normalized their blood sugar levels. The development of type 2 diabetes was monitored over a period of up to a further 9 years. Without weight loss, this group was up to 71 percent less likely to develop diabetes. This figure is almost identical to that of individuals who were able to reduce their risk of type 2 diabetes by losing weight (73 percent).

Fat Distribution as a Decisive Factor

The analysis paid particular attention to fat distribution. The relationship between visceral fat (the inner abdominal fat surrounding the organs) and subcutaneous fat (the fatty tissue located directly under the skin) was examined. Visceral fat releases signaling molecules that promote inflammation and disrupt hormone balance, which leads to insulin resistance and is thus directly linked to type 2 diabetes. Study participants whose blood sugar levels returned to normal without losing weight had a lower percentage of abdominal fat as a result of lifestyle changes compared to those whose blood sugar levels remained in the prediabetes range.

Body Weight No Longer the Sole Indicator

"Restoring a normal fasting blood sugar level is the most important goal in preventing type 2 diabetes and not necessarily the number on the scale," says Prof. Dr. Andreas Birkenfeld, study leader and director of the Institute for Diabetes Research and Metabolic Diseases (IDM) of Helmholtz Munich at the University of Tübingen. "Exercise and a balanced diet have a positive effect on blood sugar levels, regardless of whether weight is reduced. Losing weight remains helpful, but our data suggests that it is not essential for protection against diabetes," he continues. "In future, guidelines for the prevention and treatment of type 2 diabetes should not only take weight into account, but above all blood glucose control and fat distribution patterns," adds Prof. Dr. Reiner Jumpertz-von Schwartzenberg, who, as last author, was involved in the study alongside Prof. Dr. Birkenfeld.

A Healthy Lifestyle as a Recipe for Success

However, the study results highlight the importance of including target glycemic values, i.e., guideline blood sugar values, in practice guidelines in addition to weight reduction targets. Prediabetes remission is the most effective way to prevent future type 2 diabetes, and the analysis suggests that this is partly independent of weight loss. Nevertheless, sufficient physical activity and a balanced diet remain the key means to bring blood sugar values within a normal range.

Read more …You don’t have to lose weight to lower your diabetes risk, scientists say

More Articles …